Miera AV TPS (MC1AVR1); Miera A V2 TPS (MC2AVR1); Miera TPS (MC1VR01); Miera VR2 TPS (MC2VR01)
Medtronic, Inc. · Decision date Sep 5, 2025
What did the FDA decide?
FDA records P150033/S216 as a supplement to PMA P150033, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 5, 2025.
FDA approval order statement
implementation of a new visual inspection procedure
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 5, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150033/S216
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- PNJ
- Decision code
- OK30
- Decision date
- Sep 5, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Leadless pacemaker.
- Applicant
- Medtronic, Inc.
- Product code
- PNJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150033. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150033 · Original PMA
MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM
P150033/S213 · Related supplement
MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM
P150033/S214 · Related supplement
Micra AV TPS MC1AVR1; Micra AV2 TPS MC2AVR1; Micra TPS MC1VR01; Micra VR2 TPS MC2VR01
P150033/S212 · Related supplement
Micra Transcatheter Pacing System (Micra AV/VR and Micra AV2/VR2)
P150033/S216 received
Application receipt date recorded by FDA.
P150033/S208 · Related supplement
MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEM
P150033/S215 · Related supplement
Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)
P150033/S216 · FDA decision
30-Day Notice
P150033/S217 · Related supplement
Micra Transcatheter Pacing Systems
P150033/S218 · Related supplement
Micra A V2 TPS (MC2AVR1); Micra VR2 TPS (MC2VR01)
P150033/S219 · Related supplement
Micra AV TPS MC1AVR1 PNJ Micra AV2 TPS MC2AVR1 PNJ Micra TPS MC1VR01 PNJ Micra VR2 TPS MC2VR01
P150033/S220 · Related supplement
Micra AV2 TPS; Micra VR2 TPS
P150033/S221 · Related supplement
Micra Transcatheter Pacing System (MC1VR01), Micra AV Transcatheter Pacing System (MC1AVR1), Micra VR2 Transcatheter Pac
P150033/S222 · Related supplement
Miera AV TPS; Miera TPS
P150033/S225 · Related supplement
Micra Transcatheter Pacing System
P150033/S223 · Related supplement
Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)
P150033/S226 · Related supplement
Micra AV TPS; Micra AV2 TPS; Micra TPS; Micra VR2 TPS
P150033/S227 · Related supplement
Micra Cathode Press Station 2
P150033/S224 · Related supplement
Micra Scalable Catheter Delivery System (Micra AV TPS MC1AVR1; Micra AV2 TPS MC2AVR1; Micra TPS MC1VR01; Micra VR2 TPS
P150033/S228 · Related supplement
Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)
P150033/S229 · Related supplement
Micra AV TPS (MC1AVR1); Micra AV2 TPS (MC2AVR1); Micra TPS (MC1VR01); Micra VR2 TPS (MC2VR01)
P150033/S230 · Related supplement
Micra Functional Testing on pNGHT and NGHT
Timeline entries are records held by MedtechLedger for P150033. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150033
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA approval | Apr 6, 2016 | FDA | |
MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEMP150033/S213 | Medtronic, Inc. | PMA supplement | Jul 29, 2025 | FDA |
| Medtronic, Inc. | PMA supplement | Aug 12, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Aug 15, 2025 | FDA | |
MEDTRONIC MICRA TRANSCATHETER PACEMAKER SYSTEMP150033/S208 | Medtronic, Inc. | PMA supplement | Aug 20, 2025 | FDA |
| Medtronic, Inc. | PMA supplement | Aug 21, 2025 | FDA | |
Micra Transcatheter Pacing SystemsP150033/S217 | Medtronic, Inc. | PMA supplement | Nov 25, 2025 | FDA |
| Medtronic, Inc. | PMA supplement | Dec 2, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Dec 3, 2025 | FDA | |
Micra AV2 TPS; Micra VR2 TPSP150033/S220 | Medtronic, Inc. | PMA supplement | Feb 10, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Feb 11, 2026 | FDA | |
Miera AV TPS; Miera TPSP150033/S222 | Medtronic, Inc. | PMA supplement | Feb 23, 2026 | FDA |
Micra Transcatheter Pacing SystemP150033/S225 | Medtronic, Inc. | PMA supplement | Apr 22, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Apr 30, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Apr 30, 2026 | FDA | |
Micra Cathode Press Station 2P150033/S227 | Medtronic, Inc. | PMA supplement | May 8, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Jun 4, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA | |
Micra Functional Testing on pNGHT and NGHTP150033/S230 | Medtronic, Inc. | PMA supplement | Sep 8, 2026 | FDA |
Explore the linked device profile
Other records with product code PNJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AVEIR VR Real-World Evidence StudyP150035/S042 | ABBOTT MEDICAL | PMA supplement | Oct 21, 2026 | FDA |
Aveir VR Leadless SystemP150035/S041 | ABBOTT MEDICAL | PMA supplement | Aug 27, 2026 | FDA |
Aveir Leadless SystemP150035/S035 | ABBOTT MEDICAL | PMA supplement | Jul 21, 2026 | FDA |
AVEIR Patient Transmitter LSRM01P150035/S040 | ABBOTT MEDICAL | PMA supplement | Jun 17, 2026 | FDA |
The AVEIR Leadless Pacemaker (LP)P150035/S039 | ABBOTT MEDICAL | PMA supplement | Jun 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P150033/S216
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records







